Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
TNF-alpha: Roles in pathogenesis and therapeutics in cancer.
Journal: The Journal of biological chemistry
Published: July 08, 2025
TNF-alpha: Roles in Pathogenesis and Therapeutics in Cancer.
Journal: The Journal of biological chemistry
Published: July 08, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.
Journal: Nature communications
Published: September 27, 2024
Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: June 07, 2024
Hypophosphatemia Correction Reduces ICANS Incidence and Duration in CAR T-cell Therapy: A Pooled Clinical Trial Analysis.
Journal: Cancer research communications
Published: April 30, 2024
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.
Journal: Cancer immunology research
Published: July 18, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.
Journal: Cancer research communications
Published: May 07, 2023
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
Journal: Journal for immunotherapy of cancer
Published: April 11, 2023
Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report.
Journal: Frontiers in immunology
Published: February 01, 2023
Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing.
Journal: Briefings in bioinformatics
Published: December 30, 2022
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 26, 2022
Hypophosphatemia Due to Increased Effector Cell Metabolic Activity Is Associated with Neurotoxicity Symptoms in CD19-Targeted CAR T-cell Therapy.
Journal: Cancer immunology research
Published: May 24, 2022
Last Updated: 09/26/2026